Suvretta Capital Management, LLC Soleno Therapeutics Inc Transaction History

Suvretta Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$1.24 - $3.3 $7.14 Million - $19 Million	-5,758,200 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$1.61 - $2.23 $4.08 Million - $5.65 Million	2,531,447 Added 78.45%	5,758,200 $11.1 Million
Q3 2020 Nov 16, 2020	BUY	$1.71 - $2.51 $1.2 Million - $1.76 Million	699,378 Added 27.67%	3,226,753 $8.1 Million
Q2 2020 Aug 14, 2020	BUY	$1.77 - $4.23 $4.47 Million - $10.7 Million	2,527,375 New	2,527,375 $5.61 Million

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $441M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Suvretta Capital Management, LLC with notifications on news.